Boston, MA -- (SBWIRE) -- 05/12/2017 -- Downstream Processing Market by Technique (Separation, Concentration, Purification), Product (Chromatography Column & Resin, Filter, Single use), Application (Mab Production), End User (Contract Manufacturing Organization) - Global Forecast to 2021

The global downstream processing market is projected to reach USD 22.03 billion by 2021 from USD 10.32 billion in 2016, at a CAGR of 16.4% from 2016 to 2021. Increasing demand for biopharmaceuticals and increasing R&D expenditure in the biopharmaceutical industry are the major factors driving the growth of the global downstream processing market.

Get More Details on this Report and a Full Table of Contents at Downstream Processing Market - Global Forecast to 2021

Developing markets in Asia-Pacific such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore are lucrative markets for downstream processing, rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players, and increasing outsourcing services by various pharmaceutical companies from these countries are the major factors driving the growth of the downstream processing market in this region.

In this report, the downstream processing market is broadly segmented on the basis of technique, product, application, end user, and region. Based on application, the downstream processing market is classified into monoclonal antibody (mAbs) production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and other applications. The mAbs production segment is expected to grow at the fastest CAGR during the forecast period. This high growth is attributed to the increasing adoption of targeted immunotherapy and increasing number of U.S. FDA-cleared therapeutic monoclonal antibodies.

On the basis of technique, the market is segmented into purification, solid-liquid separation, and clarification/concentration. In 2016, the purification segment accounted for the largest share of the downstream processing market. The large share as well as the high growth of this segment is attributed to the growing need for highly pure biopharmaceutical products.

On the basis of product, the downstream processing market is segmented into chromatography columns and resins, filters, membrane adsorbers, single-use products, and other products. In 2016, the chromatography columns and resins segment accounted for the largest share of the downstream processing market. The constant need for newer and different types of columns and resins is likely to fuel market growth.

On the basis of end user, the downstream processing market is segmented into biopharmaceutical manufacturers and contract manufacturing organizations (CMOs). The contract manufacturing organizations (CMOs) segment is expected to grow at the highest CAGR during the forecast period.

New and innovative product launches was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs. Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), and Danaher Corporation (U.S.) are some of the leading manufacturing companies that adopted this strategy.

Research Coverage:

From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and challenges). The report also offers market sizes and data on the growth of various segments of the industry. It focuses on emerging and high-growth segments, and high-growth regions. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the downstream processing market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to buy this report:

From an insight perspective, this research report focuses on various levels of analysis-industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the downstream processing market; high-growth regions; and market drivers, restraints, and opportunities.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Biotechnology research reports at Fast Market Research

You may also be interested in these related reports:

-Antibody Production Market - Global Forecast to 2021
-Pharmaceutical Membrane Filtration Market - Global Forecast to 2021
-Laboratory Filtration Market - Global Forecast to 2021
-Pharmaceutical Filtration Market - Global Forecast to 2021
-Metabolomics Market - Forecast to 2021